ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

A JAMA study published Monday finds the average number of patents on small-molecule drugs more than tripled since 1990, rising from 2.1 patents per drug. Researchers say pharmaceutical companies are exploiting the US patent system to keep prices high, a practice that contributes to Americans paying far more for medicines than people in peer countries.
Tap to vote and see what everyone thinks.
Summary by ByteBrief